Circulating levels of GDF15 are raised in a range of human malignancies, including malignant glioma (71), pancreatic cancer (116, 117), colorectal cancer (72, 80, 118), and prostate cancer (29, 119–121). This evidence concerns the gene GDF15 and prostate cancer.